Triple therapy for BRAFV600-mutated melanoma

被引：0
|
作者：
Ribas, Antoni [1 ]
机构：
[1] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
来源：
LANCET | 2020年 / 395卷 / 10240期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [1] EPIDEMIOLOGY OF BRAFV600-MUTATED METASTATIC MELANOMA IN EUROPE: A SYSTEMATIC REVIEW
    Rahhali, N.
    Chalem, Y.
    Arkoub, H.
    Chollet, J.
    Bobrowska, A.
    Drane, E.
    Uchea, C.
    Wulund, L.
    Leonard, S.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A413 - A413
  • [2] An imaging study of vemurafenib in patients with BRAFV600-mutated metastatic melanoma.
    Lastoria, Secondo
    Grimaldi, Antonio M.
    Aloj, Luigi
    Simeone, Ester
    Romano, Anna
    Caraco, Corradina
    Curvietto, Marcello
    Esposito, Assunta
    Caraco, Corrado
    Mozzillo, Nicola
    Torri, Valter
    Ascierto, Paolo Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma
    Amann, V. C.
    Hoffmann, D.
    Mangana, J.
    Dummer, R.
    Goldinger, S. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : 1638 - 1640
  • [4] Plasma proteome alterations by MAPK inhibitors in BRAFV600-mutated metastatic cutaneous melanoma
    Babacic, Haris
    Eriksson, Hanna
    Pernemalm, Maria
    [J]. NEOPLASIA, 2021, 23 (08): : 783 - 791
  • [5] Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib
    Aglietta, Massimo
    Chiarion-Sileni, Vanna
    Fava, Paolo
    Guidoboni, Massimo
    Depenni, Roberta
    Minisini, Alessandro
    Consoli, Francesca
    Ascierto, Paolo Antonio
    Rinaldi, Gaetana
    Banzi, Maria
    Marconcini, Riccardo
    Gueli, Rossana
    Ferraresi, Virginia
    Tucci, Marco
    Tonini, Giuseppe
    Lo Re, Giovanni
    Guida, Michele
    Del Vecchio, Michele
    Marcon, Ilaria Gioia
    Queirolo, Paola
    [J]. TUMORI JOURNAL, 2023, 109 (06): : 537 - 545
  • [6] TERT promoter mutations in patients with BRAFV600-mutated melanoma treated with vemurafenib or cobimetinib combined with vemurafenib
    Wongchenko, M. J.
    Larkin, J.
    Mcarthur, G. A.
    Ribas, A.
    Dreno, B.
    Chapman, P. B.
    Maio, M.
    Garbe, C.
    Robert, C.
    Lu, W.
    Diala, I.
    Darbonne, W. C.
    Chang, I.
    Hsu, J. J.
    Caro, I.
    Rooney, I.
    Ascierto, P. A.
    Yan, Y.
    [J]. MELANOMA RESEARCH, 2016, 26 : E40 - E41
  • [7] Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
    Ribas, Antoni
    Gonzalez, Rene
    Pavlick, Anna
    Hamid, Omid
    Gajewski, Thomas F.
    Daud, Adil
    Flaherty, Lawrence
    Logan, Theodore
    Chmielowski, Bartosz
    Lewis, Karl
    Kee, Damien
    Boasberg, Peter
    Yin, Ming
    Chan, Iris
    Musib, Luna
    Choong, Nicholas
    Puzanov, Igor
    McArthur, Grant A.
    [J]. LANCET ONCOLOGY, 2014, 15 (09): : 954 - 965
  • [8] Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAFV600-mutated Metastatic Melanoma
    Yan, Yibing
    Wongchenko, Matthew J.
    Robert, Caroline
    Larkin, James
    Ascierto, Paolo A.
    Dreno, Brigitte
    Maio, Michele
    Garbe, Claus
    Chapman, Paul B.
    Sosman, Jeffrey A.
    Shi, Zhen
    Koeppen, Hartmut
    Hsu, Jessie J.
    Chang, Ilsung
    Caro, Ivor
    Rooney, Isabelle
    McArthur, Grant A.
    Ribas, Antoni
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3239 - 3246
  • [9] Effects of Molecular Heterogeneity on Survival of Patients With BRAFV600-Mutated Melanoma Treated With Vemurafenib With or Without Cobimetinib in the coBRIM Study
    Wongchenko, Matthew J.
    Ribas, Antoni
    Ascierto, Paolo A.
    Dreno, Brigitte
    di Giacomo, Anna Maria
    Garbe, Claus
    Chang, Ilsung
    Hsu, Essie
    Rooney, Isabelle
    Lu, William
    Koeppen, Hartmut
    Larkin, James
    Yan, Yibing
    McArthur, Grant A.
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 18
  • [10] Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases
    Berking, C.
    Schadendorf, D.
    Weichenthal, M.
    Eigentler, T.
    Mohr, P.
    Schober, K.
    Kiecker, F.
    Loquai, C.
    Debus, D.
    Gutzmer, R.
    Leiter-Stoeppke, U.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S755 - S755
12345